MedTrace Logo

Effect of PPV+ILM Peeling +/- Subretinal Injection of Ringer Lactate in Management of Nontractional Refractory DME

NCT06271473 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-08-06

No results posted yet for this study

Summary

To evaluate the efficacy and safety of combined pars plana vitrectomy and planned foveal detachment through subretinal injection of ringer's solution in patients with non-tractional refractory diabetic macular edema.

Conditions

  • Efficacy
  • Safety

Interventions

PROCEDURE

vitrectomy + ILM peeling +/- planned foveal detachment via subretinal injection of ringer's solution.

vitrectomy + ILM peeling +/- planned foveal detachment via subretinal injection of ringer's solution.

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Abdelrahman G Salman, MD · professor at Ain Shams university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-30
Primary Completion
2024-12-30
Completion
2025-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06271473 on ClinicalTrials.gov